Pharmacology Intensive Exam
Review: High-Yield Concepts Q&A
(2026 Edition)|| Questions And
Answers With Rationales/Graded
A+/2026 Update/100% Correct
/Instant Download
Instructions: Choose the single best answer for each question. Correct answers
are highlighted in bold. A rationale is provided for each.
SECTION A: PHARMACODYNAMICS & PHARMACOKINETICS (Qs 1-
12)
1. A drug that binds to a receptor and produces a maximal biologic response
identical to the endogenous ligand is best described as:
• A) Partial agonist
• B) Inverse agonist
• C) Antagonist
• D) Full agonist
*Rationale: A full agonist has high intrinsic activity (efficacy = 1). A partial agonist
produces submaximal response even at full receptor occupancy.*
2. Which parameter is most clinically useful for determining dosing
frequency?
• A) Volume of distribution (Vd)
• B) Bioavailability (F)
• C) Half-life (t½)
, • D) Potency (EC50)
Rationale: Half-life dictates the time to steady state and how often a drug must be
administered to maintain therapeutic levels.
3. A patient with liver failure has reduced albumin. How will this affect a
highly protein-bound drug like phenytoin?
• A) Increased free drug concentration
• B) Decreased volume of distribution
• C) Reduced hepatic extraction
• D) Increased protein binding
Rationale: Hypoalbuminemia leads to more unbound (free) active drug, increasing
effect and risk of toxicity despite normal total drug levels.
4. Zero-order kinetics is best exemplified by:
• A) Most beta-lactam antibiotics
• B) Phenytoin at therapeutic doses
• C) Lidocaine
• D) Ethanol at low doses
Rationale: Phenytoin, high-dose aspirin, and ethanol saturate metabolizing
enzymes, leading to constant amount eliminated per unit time, not constant
fraction.
5. Which drug interaction involves inhibition of CYP3A4 leading to toxicity?
• A) Rifampin + warfarin
• B) Clarithromycin + simvastatin
• C) Phenobarbital + oral contraceptive
• D) St. John’s wort + cyclosporine
Rationale: Clarithromycin is a strong CYP3A4 inhibitor, increasing simvastatin
levels, risk of rhabdomyolysis.
6. The therapeutic index (TI) is calculated as:
, • A) ED50 / TD50
• B) TD50 / ED50
• C) ED50 / LD50
• D) LD1 / ED99
*Rationale: TI = TD50 (or LD50) divided by ED50. A low TI (e.g., warfarin,
digoxin) indicates narrow margin of safety.*
7. A drug with a very large volume of distribution (e.g., >1000 L) suggests:
• A) Confined to plasma compartment
• B) Extensive tissue binding
• C) High protein binding only
• D) Rapid renal elimination
Rationale: High Vd means drug concentrates in tissues (e.g., digoxin in muscle,
chloroquine in liver). Not removed efficiently by dialysis.
8. First-pass effect reduces bioavailability of which route?
• A) Intravenous
• B) Sublingual
• C) Oral
• D) Transdermal
Rationale: Oral drugs pass through the portal circulation to the liver, where
metabolism may occur before reaching systemic circulation.
9. Which drug requires loading dose to achieve rapid therapeutic effect
despite long half-life?
• A) Metoprolol
• B) Amiodarone
• C) Furosemide
• D) Lidocaine (IV)
Review: High-Yield Concepts Q&A
(2026 Edition)|| Questions And
Answers With Rationales/Graded
A+/2026 Update/100% Correct
/Instant Download
Instructions: Choose the single best answer for each question. Correct answers
are highlighted in bold. A rationale is provided for each.
SECTION A: PHARMACODYNAMICS & PHARMACOKINETICS (Qs 1-
12)
1. A drug that binds to a receptor and produces a maximal biologic response
identical to the endogenous ligand is best described as:
• A) Partial agonist
• B) Inverse agonist
• C) Antagonist
• D) Full agonist
*Rationale: A full agonist has high intrinsic activity (efficacy = 1). A partial agonist
produces submaximal response even at full receptor occupancy.*
2. Which parameter is most clinically useful for determining dosing
frequency?
• A) Volume of distribution (Vd)
• B) Bioavailability (F)
• C) Half-life (t½)
, • D) Potency (EC50)
Rationale: Half-life dictates the time to steady state and how often a drug must be
administered to maintain therapeutic levels.
3. A patient with liver failure has reduced albumin. How will this affect a
highly protein-bound drug like phenytoin?
• A) Increased free drug concentration
• B) Decreased volume of distribution
• C) Reduced hepatic extraction
• D) Increased protein binding
Rationale: Hypoalbuminemia leads to more unbound (free) active drug, increasing
effect and risk of toxicity despite normal total drug levels.
4. Zero-order kinetics is best exemplified by:
• A) Most beta-lactam antibiotics
• B) Phenytoin at therapeutic doses
• C) Lidocaine
• D) Ethanol at low doses
Rationale: Phenytoin, high-dose aspirin, and ethanol saturate metabolizing
enzymes, leading to constant amount eliminated per unit time, not constant
fraction.
5. Which drug interaction involves inhibition of CYP3A4 leading to toxicity?
• A) Rifampin + warfarin
• B) Clarithromycin + simvastatin
• C) Phenobarbital + oral contraceptive
• D) St. John’s wort + cyclosporine
Rationale: Clarithromycin is a strong CYP3A4 inhibitor, increasing simvastatin
levels, risk of rhabdomyolysis.
6. The therapeutic index (TI) is calculated as:
, • A) ED50 / TD50
• B) TD50 / ED50
• C) ED50 / LD50
• D) LD1 / ED99
*Rationale: TI = TD50 (or LD50) divided by ED50. A low TI (e.g., warfarin,
digoxin) indicates narrow margin of safety.*
7. A drug with a very large volume of distribution (e.g., >1000 L) suggests:
• A) Confined to plasma compartment
• B) Extensive tissue binding
• C) High protein binding only
• D) Rapid renal elimination
Rationale: High Vd means drug concentrates in tissues (e.g., digoxin in muscle,
chloroquine in liver). Not removed efficiently by dialysis.
8. First-pass effect reduces bioavailability of which route?
• A) Intravenous
• B) Sublingual
• C) Oral
• D) Transdermal
Rationale: Oral drugs pass through the portal circulation to the liver, where
metabolism may occur before reaching systemic circulation.
9. Which drug requires loading dose to achieve rapid therapeutic effect
despite long half-life?
• A) Metoprolol
• B) Amiodarone
• C) Furosemide
• D) Lidocaine (IV)
